Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients (Clinical and Experimental Nephrology, (2022), 26, 6, (571-580), 10.1007/s10157-022-02188-y)

Masataro Toda; Ayumi Yoshifuji; Kan Kikuchi; Masayoshi Koinuma; Motoaki Komatsu; Kentaro Fujii; Ai Kato; Takahide Kikuchi; Atsushi Nakazawa; Munekazu Ryuzaki

doi:10.1007/s10157-022-02203-2

Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients (Clinical and Experimental Nephrology, (2022), 26, 6, (571-580), 10.1007/s10157-022-02188-y)

Masataro Toda, Ayumi Yoshifuji, Kan Kikuchi, Masayoshi Koinuma, Motoaki Komatsu, Kentaro Fujii, Ai Kato, Takahide Kikuchi, Atsushi Nakazawa, Munekazu Ryuzaki

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original publication, the author has found errors as below.

Original language	English
Pages (from-to)	581-582
Number of pages	2
Journal	Clinical and experimental nephrology
Volume	26
Issue number	6
DOIs	https://doi.org/10.1007/s10157-022-02203-2
Publication status	Published - 2022 Jun
Externally published	Yes

ASJC Scopus subject areas

Physiology
Nephrology
Physiology (medical)

Access to Document

10.1007/s10157-022-02203-2

Fingerprint

Dive into the research topics of 'Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients (Clinical and Experimental Nephrology, (2022), 26, 6, (571-580), 10.1007/s10157-022-02188-y)'. Together they form a unique fingerprint.

Cite this

Toda, M., Yoshifuji, A., Kikuchi, K., Koinuma, M., Komatsu, M., Fujii, K., Kato, A., Kikuchi, T., Nakazawa, A., & Ryuzaki, M. (2022). Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients (Clinical and Experimental Nephrology, (2022), 26, 6, (571-580), 10.1007/s10157-022-02188-y). Clinical and experimental nephrology, 26(6), 581-582. https://doi.org/10.1007/s10157-022-02203-2

Correction to : Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients (Clinical and Experimental Nephrology, (2022), 26, 6, (571-580), 10.1007/s10157-022-02188-y). / Toda, Masataro; Yoshifuji, Ayumi; Kikuchi, Kan et al.

In: Clinical and experimental nephrology, Vol. 26, No. 6, 06.2022, p. 581-582.

Research output: Contribution to journal › Comment/debate › peer-review

Toda, M, Yoshifuji, A, Kikuchi, K, Koinuma, M, Komatsu, M, Fujii, K, Kato, A, Kikuchi, T, Nakazawa, A & Ryuzaki, M 2022, 'Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients (Clinical and Experimental Nephrology, (2022), 26, 6, (571-580), 10.1007/s10157-022-02188-y)', Clinical and experimental nephrology, vol. 26, no. 6, pp. 581-582. https://doi.org/10.1007/s10157-022-02203-2

Toda M, Yoshifuji A, Kikuchi K, Koinuma M, Komatsu M, Fujii K et al. Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients (Clinical and Experimental Nephrology, (2022), 26, 6, (571-580), 10.1007/s10157-022-02188-y). Clinical and experimental nephrology. 2022 Jun;26(6):581-582. doi: 10.1007/s10157-022-02203-2

@article{151619324dfd43e4b9a13eb30a061899,

title = "Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients (Clinical and Experimental Nephrology, (2022), 26, 6, (571-580), 10.1007/s10157-022-02188-y)",

abstract = "In the original publication, the author has found errors as below.",

author = "Masataro Toda and Ayumi Yoshifuji and Kan Kikuchi and Masayoshi Koinuma and Motoaki Komatsu and Kentaro Fujii and Ai Kato and Takahide Kikuchi and Atsushi Nakazawa and Munekazu Ryuzaki",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = jun,

doi = "10.1007/s10157-022-02203-2",

language = "English",

volume = "26",

pages = "581--582",

journal = "Clinical and Experimental Nephrology",

issn = "1342-1751",

publisher = "Springer Japan",

number = "6",

}

TY - JOUR

T1 - Correction to

T2 - Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients (Clinical and Experimental Nephrology, (2022), 26, 6, (571-580), 10.1007/s10157-022-02188-y)

AU - Toda, Masataro

AU - Yoshifuji, Ayumi

AU - Kikuchi, Kan

AU - Koinuma, Masayoshi

AU - Komatsu, Motoaki

AU - Fujii, Kentaro

AU - Kato, Ai

AU - Kikuchi, Takahide

AU - Nakazawa, Atsushi

AU - Ryuzaki, Munekazu

PY - 2022/6

Y1 - 2022/6

N2 - In the original publication, the author has found errors as below.

AB - In the original publication, the author has found errors as below.

UR - http://www.scopus.com/inward/record.url?scp=85125843583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85125843583&partnerID=8YFLogxK

U2 - 10.1007/s10157-022-02203-2

DO - 10.1007/s10157-022-02203-2

M3 - Comment/debate

C2 - 35262832

AN - SCOPUS:85125843583

VL - 26

SP - 581

EP - 582

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

SN - 1342-1751

IS - 6

ER -

Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients (Clinical and Experimental Nephrology, (2022), 26, 6, (571-580), 10.1007/s10157-022-02188-y)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this